Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness

NCT02162862 is registered in ClinicalTrials.gov with Eva Szigethy as lead sponsor.

NCT NCT02162862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Lead sponsor
Eva Szigethy
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
June 30, 2016
Enrollment
99 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, inflammatory bowel disease, sleep disturbance